While no details were provided, Walgreen Co. (NYSE: WAG) and Express Scripts Holding Co. (NASDAQ: ESRX) this morning announced a new multiyear deal that will once again add Walgreens stores to the pharmacy network…
Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for the first quarter of 2012. The top five sellers include drugs from Bristol-Myers Squibb…
Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but missed slightly on revenues. The drug maker reported adjusted diluted EPS of $1.23, a…
In an open letter to the board of directors of Forest Laboratories Inc. (NYSE: FRX), activist investor Carl Icahn doesn’t beat around the bush: Your recent letter has taken things a step further from…
Health care giant Johnson & Johnson (NYSE: JNJ) reported second-quarter earnings this morning, posting adjusted earnings per share (EPS) of $1.30 on revenue of $16.5 billion. The consensus estimate from analysts called for EPS…
Activist investor Carl Icahn has sent a letter to the non-executive members of the board of directors of Forest Laboratories Inc. (NYSE: FRX) asking them avoid a protracted proxy fight over his request to…
Health insurance provider Wellpoint Inc. (NYSE: WLP) announced this morning that it has reached a definitive agreement to acquire managed care provider Amerigroup Corp. (NYSE: AGP) for a total of $4.9 billion. Amerigroup shareholders…
GlobeImmune, Inc. is the latest biotech to file for an initial public offering. Financial terms were not disclosed but the first filing is for up to $69 million in common stock. This one has…
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it is effectively a split…
Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) was going to be acquired or not. Bristol-Myers Squibb Company…
Health care problems do not sit high on the list of concerns of most Americans, even if the Supreme Court just upheld most of the Affordable Care Act of 2010. The decision does not solve a “pocketbook”…
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is surging after the FDA approved its weight loss pill called BELVIQ. In fact, now that shares have reopened after having been halted this stock is up a sharp…
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was halted today for news that the company’s weight-loss drug called BELVIQ has been approved. The news is good for all obesity drug makers today. VIVUS Inc. (NASDAQ: VVUS)…
The lack of medical coverage in America is a serious problem as approximately 50 million people were uninsured all through 2010. But the U.S. Supreme Court on Thursday ruled the Patient Protection and Affordable…
Teva Pharmaceutical Industries Limited (NYSE: TEVA) are up 4.7% a $39.75 on more than 12 million shares, while Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) are down over 22% at $13.19 on more than 2 million…